Table 4.
Drug resistance to NNRTIs in newly reported HIV infections with V179D/E/T.
| HIV Drug Resistance Mutations | Number (%) | Level of Drug Resistance * | NNRTIs |
|---|---|---|---|
| Total | 101 | ||
| V179D/E/T | 90 (89.1) | - | - |
| V179D | 1 (1.0) | I | EFV, NVP |
| 1 (1.0) | L | RPV | |
| E138A, V179E | 1 (1.0) | L | ETR, RPV |
| E138G, V179E | 3 (3.0) | L | EFV, ETR, NVP, RPV |
| V106I, V179D | 1 (1.0) | L | ETR, NVP, RPV |
| K103N, V179E | 4 (4.0) | H | EFV, NVP |
* L, low level; I, intermediate level; H, high level. NNRTIs, non-nucleoside reverse transcriptase inhibitors. EFV, efavirenz; ETR, etravirine; NVP, nevirapine; RPV, rilpivirine.